GGrantIndex
← Leaderboards

Robyn S Klein

Massachusetts General Hospital

$18,056,082
Attributed
$22,691,336
Total exposure
18
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,691,336 · 18

By mechanism

R01$13,260,801 · 5
P01$4,155,591 · 4
R35$2,050,010 · 1
R56$775,277 · 1
K02$774,090 · 1
K08$480,211 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsImmuneIn VivoT-LymphocyteMolecularBlood - Brain Barrier AnatomyMouse ModelEncephalitisNeuraxisTissuesMediatingInflammationNeuronsAcuteVirusSignal TransductionInfectionCytokineViralWest Nile VirusAnimalsInflammatoryBrainPublishing

Grant awards (69)

Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2025 · AI · contact PI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$521,574
R01 · FY2024 · AI · contact PI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$616,573
R01 · FY2023 · AI · contact PI
2023 Neuroimmune Communication in Health and Disease Gordon Research Conference and Gordon Research Seminar$16,000
R13 · FY2023 · AI · contact PI
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS$1,181,250
R35 · FY2022 · NS · contact PI
Viral and host factors in neuroinvasion of encephalitis alphaviruses$634,948
R01 · FY2022 · AI · contact PI
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS$868,760
R35 · FY2021 · NS · contact PI
TAM Receptors and Virus Infection$833,577
R01 · FY2021 · AI
Astrocyte innate immune mechanisms of post-viral cognitive dysfunction$393,750
R01 · FY2021 · NS · contact PI
TAM Receptors and Virus Infection$833,577
R01 · FY2020 · AI
Innate immune mechanisms of virologic control and recovery from flavivirus encephalitis$775,277
R56 · FY2020 · AI · contact PI
NEUROPATHOGENESIS OF ZIKA VIRUS INFECTIONS$474,939
R01 · FY2020 · NS · contact PI
Neuroprotection and repair during West Nile Virus Encephalitis$333,594
R01 · FY2020 · NS · contact PI
Effect of aging on neuroinvasion during West Nile virus (WNV) infection.$154,917
UH3 · FY2020 · NS · contact PI
TAM Receptors and Virus Infection$833,577
R01 · FY2019 · AI
NEUROPATHOGENESIS OF ZIKA VIRUS INFECTIONS$459,614
R01 · FY2019 · NS · contact PI
Neuroprotection and repair during West Nile Virus Encephalitis$333,594
R01 · FY2019 · NS · contact PI
Effect of aging on neuroinvasion during West Nile virus (WNV) infection.$154,425
UH3 · FY2019 · NS · contact PI
TAM Receptors and Virus Infection$833,577
R01 · FY2018 · AI
NEUROPATHOGENESIS OF ZIKA VIRUS INFECTIONS$455,585
R01 · FY2018 · NS · contact PI
Neuroprotection and repair during West Nile Virus Encephalitis$333,594
R01 · FY2018 · NS · contact PI
Targeting the BBB to treat CNS inflammation$283,078
P01 · FY2018 · NS · contact PI
Effect of aging on neuroinvasion during West Nile virus (WNV) infection.$153,072
UH3 · FY2018 · NS · contact PI
Animal Models, Histology and Tissue Bank Core$135,345
P01 · FY2018 · NS · contact PI
TAM Receptors and Virus Infection$857,077
R01 · FY2017 · AI
Neuroprotection and repair during West Nile Virus Encephalitis$333,594
R01 · FY2017 · NS · contact PI
Targeting the BBB to treat CNS inflammation$283,079
P01 · FY2017 · NS · contact PI
Mechanisms of sex differences in blood-brain barrier biology$228,750
R21 · FY2017 · NS · contact PI
Animal Models, Histology and Tissue Bank Core$137,398
P01 · FY2017 · NS · contact PI
Effect of aging on neuroinvasion during West Nile virus (WNV) infection.$74,817
UH2 · FY2017 · NS · contact PI
Neuroprotection and repair during West Nile Virus Encephalitis$333,594
R01 · FY2016 · NS · contact PI
Targeting the BBB to treat CNS inflammation$283,078
P01 · FY2016 · NS · contact PI
Mechanisms of sex differences in blood-brain barrier biology$190,625
R21 · FY2016 · NS · contact PI
Animal Models, Histology and Tissue Bank Core$139,412
P01 · FY2016 · NS · contact PI
Effect of aging on neuroinvasion during West Nile virus (WNV) infection.$74,817
UH2 · FY2016 · NS · contact PI
Targeting the BBB to treat CNS inflammation$283,078
P01 · FY2015 · NS · contact PI
Animal Models, Histology and Tissue Bank Core$137,193
P01 · FY2015 · NS · contact PI
CHEMOKINE-MEDIATED NEUROPROTECTION AND REPAIR DURING WNV ENCEPHALITIS$322,591
R01 · FY2014 · NS · contact PI
Targeting the BBB to treat CNS inflammation$282,924
P01 · FY2014 · NS · contact PI
Animal Models, Histology and Tissue Bank Core$136,956
P01 · FY2014 · NS · contact PI
CHEMOKINE-MEDIATED NEUROPROTECTION AND REPAIR DURING WNV ENCEPHALITIS$314,445
R01 · FY2013 · NS · contact PI
CHEMOKINE-MEDIATED NEUROPROTECTION AND REPAIR DURING WNV ENCEPHALITIS$325,850
R01 · FY2012 · NS · contact PI
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases$233,219
P01 · FY2012 · NS · contact PI
ANIMAL MODEL CORE$124,323
P01 · FY2012 · NS · contact PI
CHEMOKINE-MEDIATED NEUROPROTECTION AND REPAIR DURING WNV ENCEPHALITIS$325,850
R01 · FY2011 · NS · contact PI
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases$237,444
P01 · FY2011 · NS · contact PI
ANIMAL MODEL CORE$139,614
P01 · FY2011 · NS · contact PI
CHEMOKINE-MEDIATED NEUROPROTECTION AND REPAIR DURING WNV ENCEPHALITIS$328,405
R01 · FY2010 · NS · contact PI
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases$266,673
P01 · FY2010 · NS · contact PI
ANIMAL MODEL CORE$175,457
P01 · FY2010 · NS · contact PI
Mechanisms of CXCL10-Mediated Neuroprotection in WNV Encephalitis$335,479
R01 · FY2009 · NS · contact PI
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases$281,538
P01 · FY2009 · NS · contact PI
ANIMAL MODEL CORE$188,109
P01 · FY2009 · NS · contact PI
Mechanisms of CXCL10-Mediated Neuroprotection in WNV Encephalitis$335,479
R01 · FY2008 · NS · contact PI
Neuroprotective mechanisms of CXCL12 in CNS demyelinating diseases$248,512
P01 · FY2008 · NS · contact PI
ANIMAL MODEL CORE$159,161
P01 · FY2008 · NS · contact PI
Targeting Mononuclear Cell Trafficing for the Treatment of Viral Encephalitis$147,933
U54 · FY2008 · AI · contact PI
Mechanisms of CXCL10-Mediated Neuroprotection in WNV Encephalitis$335,479
R01 · FY2007 · NS · contact PI
Chemokines and lymphocyte trafficking into the CNS$122,418
K02 · FY2007 · NS · contact PI
Mechanisms of CXCL10-Mediated Neuroprotection in WNV Encephalitis$345,498
R01 · FY2006 · NS · contact PI
Chemokines and lymphocyte trafficking into the CNS$122,418
K02 · FY2006 · NS · contact PI
Mechanisms of CXCL10-Mediated Neuroprotection in WNV Encephalitis$353,813
R01 · FY2005 · NS
Chemokines and lymphocyte trafficking into the CNS$176,418
K02 · FY2005 · NS
Chemokines and lymphocyte trafficking into the CNS$176,418
K02 · FY2004 · NS
Chemokines and lymphocyte trafficking into the CNS$129,399
K02 · FY2003 · NS
Chemokines and lymphocyte trafficking into the CNS$47,019
K02 · FY2003 · NS
CYTOTOXIC LYMPHOCYTE RESPONSES IN ACUTE HIV1 INFECTION$163,220
K08 · FY2002 · DA
CYTOTOXIC LYMPHOCYTE RESPONSES IN ACUTE HIV1 INFECTION$160,040
K08 · FY2001 · DA
CYTOTOXIC LYMPHOCYTE RESPONSES IN ACUTE HIV1 INFECTION$156,951
K08 · FY2000 · DA